Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
November 10, 2022 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 8, 2022 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 3, 2022 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 3, 2022 10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
October 7, 2022 CT ORDER

CT ORDER

View HTML
September 1, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
August 4, 2022 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 4, 2022 10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
July 18, 2022 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
July 8, 2022 SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us